Non-invasive medical devices are becoming increasingly popular due to their ability to diagnose and monitor patients without painful procedures. One major trend among these devices now is miniaturisation, pushing for smaller components enabling surgeons to reach remote body areas.
In tandem with this development, wireless capsule endoscopes represent a notable advancement. These devices, once ingested, capture images of the gastrointestinal tract, facilitating non-intrusive internal examinations.
The field is also seeing the emergence of portable, handheld ultrasound scanners. These scanners are particularly useful for point-of-care diagnosis, offering convenience and efficiency in various medical settings.
Another notable stride is seen in the realm of non-invasive prenatal testing devices. These devices can detect genetic conditions in a fetus using only a maternal blood sample, significantly reducing the risk associated with traditional prenatal testing methods.
Driven by these trends, the global market size is projected to reach $44.20 billion by 2028, growing at a CAGR of 6.59 percent globally.
This edition of MedTech Outlook Europe brings insights into the latest developments in non-invasive devices and how companies align to improve them for the populace.
It features a thought article Dr Katrien De Ketelaere, medical director at AZ Sint Lucas Ghent, who sheds light on the importance of accelerating the adoption of digital healthcare solutions, which benefits the healthcare community globally. The magazine also features an article from Prof Christopher Kipps, consultant neurologist at University Hospital Southampton NHS Foundation Trust, who educates us about three key steps to successfully embed medtech in healthcare.
We also bring to you top non-invasive device manufacturing companies offering innovative product and solutions. A noteworthy story is that of Zedsen, which provides a non-invasive, low-cost, and portable device called Z-Scanner. This device easily distinguishes between healthy and potentially malignant breast tissue in patients who are experiencing symptoms of breast cancer.
In this edition featuring the top non-invasive devices solutions providers in Europe 2023, we hope you find the right partner to meet your organisation’s needs
